Jonathon Unwin
Stock Analyst at Barclays
(0.23)
# 4,504
Out of 4,673 analysts
62
Total ratings
27.3%
Success rate
-15%
Average return
Main Sectors:
Stocks Rated by Jonathon Unwin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LON: ONT Oxford Nanopore Technologies plc | Maintained: Buy | 160p → 182p | 170p | +7.06% | 8 | Aug 21, 2026 | |
| SWX: YPSN Ypsomed Holding AG | Maintained: Buy | CHF 386.00 → CHF 480.00 | CHF 405.00 | +18.52% | 7 | Aug 18, 2026 | |
| BIT: 1SXP SCHOTT Pharma AG & Co. KGaA | Upgraded: Buy | €16.00 → €27.00 | €21.00 | +28.57% | 13 | Aug 18, 2026 | |
| ETR: AFX Carl Zeiss Meditec AG | Maintained: Hold | €28.00 → €27.00 | €32.48 | -16.87% | 11 | Aug 11, 2026 | |
| ETR: GXI Gerresheimer AG | Maintained: Sell | €17.00 → €25.00 | €27.60 | -9.42% | 9 | Jul 29, 2026 | |
| STO: VIMIAN Vimian Group AB (publ) | Maintained: Sell | kr 26.00 → kr 29.00 | kr 34.85 | -16.79% | 14 | Jul 23, 2026 |
Oxford Nanopore Technologies plc
Aug 21, 2026
Maintained: Buy
Price Target: 160p → 182p
Current: 170p
Upside: +7.06%
Ypsomed Holding AG
Aug 18, 2026
Maintained: Buy
Price Target: CHF 386.00 → CHF 480.00
Current: CHF 405.00
Upside: +18.52%
SCHOTT Pharma AG & Co. KGaA
Aug 18, 2026
Upgraded: Buy
Price Target: €16.00 → €27.00
Current: €21.00
Upside: +28.57%
Carl Zeiss Meditec AG
Aug 11, 2026
Maintained: Hold
Price Target: €28.00 → €27.00
Current: €32.48
Upside: -16.87%
Gerresheimer AG
Jul 29, 2026
Maintained: Sell
Price Target: €17.00 → €25.00
Current: €27.60
Upside: -9.42%
Vimian Group AB (publ)
Jul 23, 2026
Maintained: Sell
Price Target: kr 26.00 → kr 29.00
Current: kr 34.85
Upside: -16.79%